Showing results (51-60 of 81) with videos related to
Sort By:
Pageof 9
Cancer Research|April 3, 2004
Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targetsLaura J Rush, Aparna Raval, Pauline Funchain, et al.Journal for Immunotherapy of Cancer|April 11, 2024
Autologous human preclinical modeling of melanoma interpatient clinical responses to immunotherapeuticsYee Peng Phoon, Jared E Lopes, Lukas W Pfannenstiel, et al.JCO Precision Oncology|February 9, 2022
Precision Oncology in Solid Tumors: A Longitudinal Tertiary Care Center ExperienceMeena Sadaps, Pauline Funchain, Haider Mahdi, et al.Journal of Neurosurgery|August 12, 2017
Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcomeRupesh Kotecha, Jacob A Miller, Vyshak A Venur, et al.Future Oncology (London, England)|August 30, 2022
A phase II study of TAS-117 in patients with advanced solid tumors harboring germline PTEN-inactivating mutationsJordi Rodón, Pauline Funchain, Theodore W Laetsch, et al.Journal of the National Cancer Institute|November 11, 2015
Prospective Clinical Study of Precision Oncology in Solid TumorsDavendra P S Sohal, Brian I Rini, Alok A Khorana, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 18, 2025
Worse Survival and Gastrointestinal Toxicity Outcomes Among Patients Receiving Proton Pump Inhibitors During Checkpoint Inhibitor TherapyMalek Shatila, Samanthika Devalaraju, Kei Takigawa, et al.Med (New York, N.Y.)|May 26, 2021
Increased Incidence of Venous Thromboembolism with Cancer ImmunotherapyJoanna Roopkumar, Shadi Swaidani, Ann S Kim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2019
Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated ColitisHamzah Abu-Sbeih, Faisal S Ali, Abdul Rafeh Naqash, et al.Expert Opinion on Drug Safety|February 23, 2026
Chronic sequelae of immune-related adverse eventsSean Ngo, Jarrett Rong, Raakhi Menon, et al.Pageof 9